Xilio Therapeutics, Inc. Share Price
NASDAQ: XLO | Micro CapXilio Therapeutics, Inc. Stock Performance
Xilio Therapeutics, Inc. Share Price Today
As of 18 November 2026, Xilio Therapeutics, Inc.'s share price is $7.80. The stock opened at $7.80, compared to its previous close of $7.60. During today's trading session, Xilio Therapeutics, Inc.'s share price traded between $7.80 and $7.80, with an average price of $7.80. Over the past 52 weeks, the stock has recorded a high of $9.75 and a low of $0.47. In terms of performance, Xilio Therapeutics, Inc.'s share price has declined by 7.91% over the last six months and is up 937.90% on a year-on-year basis.
Xilio Therapeutics, Inc. Share Price Chart
Xilio Therapeutics, Inc. Quarterly Profit & Loss
All figures in USD
Xilio Therapeutics, Inc. Annual Profit & Loss
All figures in USD
About Xilio Therapeutics, Inc.
Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.
Xilio Therapeutics, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $7.82 | $7.80 | -4.12% |
Oct 2026 | $9.00 | $8.14 | -9.45% |
Sep 2026 | $9.05 | $8.99 | -1.69% |
Aug 2026 | $9.18 | $9.14 | -0.27% |
Jul 2026 | $9.08 | $9.17 | -3.22% |
Jun 2026 | $8.43 | $9.47 | +11.80% |
May 2026 | $8.43 | $8.47 | +6.47% |
Apr 2026 | $8.58 | $7.96 | -6.02% |
Mar 2026 | $0.52 | $8.47 | +1,495.10% |
Feb 2026 | $0.58 | $0.53 | -10.30% |
Jan 2026 | $0.64 | $0.59 | -7.93% |
Dec 2025 | $0.75 | $0.64 | -14.49% |